 The high cost of biology laboratory work is making health care inaccessible. In the United States, a blood test on average costs $1,500 per test. A drug discovery company on average spends over a billion dollars in developing one single drug. A big chunk of this cost comes from specialty machines and the use of disposables such as pipette dips. So we have been developing a low-cost lab-on-a-chip technology based on a physical principle called electro-wedding, where we use electric fields to move, merge, stir and analyze tiny biological samples. So fundamentally what we are doing in our chip is to charge and discharge tiny metal plates. Discharging and discharging of these metal plates attracts and repels tiny droplets. And by sequentially turning on and off these metal electrodes, you can gently shuttle a drop from one location to another. We developed a new surface coating that prevents droplets from leaving a trail behind and thus preventing contamination between droplets which could cross each other. Biologists in a lab spend on average 30-50% of their time manually moving fluids. And this task is not only tedious but is also error-prone. On top of that, each of these labs produce massive amounts of hazardous trash in the form of pipette dips. In our own lab, we've been running various experiments on our chip to reduce the dependency on pipettes by over 10-fold. Of course, you can replace the human with a pipetting robot. But each of these machines have their own definition for what a protocol is. And there are multiple research laboratories developing their own standard. So we want to change this. This will enable a way for biologists to create a shared protocol that millions of people can use. If you look at the biology industry which uses the traditional machinery with pipes, valves and tubes, the number of experiments that you can run at once is limited by the mechanism. Today, on one of our chips, we can manipulate multiple samples at the same time. We want to use our technology to improve the capacity of existing machines to be able to manipulate over a million samples on a single chip. This new capability could enable the discovery of new drugs faster and find markers for unknown diseases. I come from India where often healthcare testing is a luxury. Modern healthcare testing facilities around the world do not scale economically to provide affordable healthcare. My hope is that we can bring affordable healthcare through lab-on-chip technologies to billions of people around the world.